| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shakir YA et al. | Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women's Health in the Lund Area study. | 2004 Sep-Oct | Menopause | pmid:15356408 |
| pmid:15360204 | ||||
| pmid:15360211 | ||||
| Tedone L et al. | Long-distance transport of L-ascorbic acid in potato. | 2004 | BMC Plant Biol. | pmid:15377389 |
| TYLER ET et al. | LONG TERM USAGE OF NORETHINDRONE WITH MESTRANOL PREPARATIONS IN THE CONTROL OF HUMAN FERTILITY. | 1964 | Clin Med (Northfield) | pmid:15446181 |
| Dahmoun M et al. | Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT. | 2004 | Maturitas | pmid:15474755 |
| Beckman M | Wayward sisters. Progestin siblings exert opposite effects on monkey hearts. | 2004 | Sci Aging Knowledge Environ | pmid:15483332 |
| Graff-Iversen S et al. | Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women. | 2004 | J. Intern. Med. | pmid:15485480 |
| Faludi AA et al. | Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. | 2004 | Atherosclerosis | pmid:15488870 |
| Hapgood JP et al. | Not all progestins are the same: implications for usage. | 2004 | Trends Pharmacol. Sci. | pmid:15491776 |
| Perrone JA et al. | Weight loss dynamics during combined fluoxetine and olanzapine treatment. | 2004 | BMC Pharmacol. | pmid:15498104 |
| Woods ER et al. | Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients. | 1992 | Am. J. Obstet. Gynecol. | pmid:1550161 |
| Nunes FM et al. | The use of Open Reading frame ESTs (ORESTES) for analysis of the honey bee transcriptome. | 2004 | BMC Genomics | pmid:15527499 |
| Pedersen NG et al. | Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. | 2004 | Maturitas | pmid:15531126 |
| Piccioni P et al. | Hormonal replacement therapy after stem cell transplantation. | 2004 | Maturitas | pmid:15531129 |
| Wasnich RD et al. | Changes in bone density and turnover after alendronate or estrogen withdrawal. | 2004 Nov-Dec | Menopause | pmid:15545790 |
| Fröhlich M et al. | In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins. | 2004 | Biochem. Pharmacol. | pmid:15548387 |
| Faassen F and Vromans H | Biowaivers for oral immediate-release products: implications of linear pharmacokinetics. | 2004 | Clin Pharmacokinet | pmid:15568890 |
| pmid:15575667 | ||||
| Kwok S et al. | Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy. | 2004 | Clin. Endocrinol. (Oxf) | pmid:15579192 |
| pmid:15587804 | ||||
| Oettinger M et al. | Subcutaneous implantation of pure crystalline estradiol pellets for conception control. | 2005 | Gynecol. Obstet. Invest. | pmid:15591820 |
| Kulcsár A and Kulcsár-Gergely J | Administration of progesterone and progestogens in chronical liver injury. | 1979 | Arzneimittelforschung | pmid:156027 |
| Kulcsár-Gergely J and Kulcsár A | The sexual cycle in rats during progesterone and progestogen treatment. | 1979 | Arzneimittelforschung | pmid:156028 |
| Meriggiola MC et al. | Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15634716 |
| Hugues JN | [The programming of IVF cycles with antagonists]. | 2004 | J Gynecol Obstet Biol Reprod (Paris) | pmid:15643680 |
| Takenaka T et al. | Judicious usage of estrogen/progesterone for angiodysplasia. | 2005 | Artif Organs | pmid:15644090 |
| Junkermann H et al. | Influence of different HRT regimens on mammographic density. | 2005 | Maturitas | pmid:15653007 |
| Farkas M et al. | [Use of Bromocriptin tablets in physiologic and pathologic hyperprolactinemia]. | 1992 Jan-Feb | Acta Pharm Hung | pmid:1566636 |
| Levine DW et al. | Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial. | 2005 Jan-Feb | Psychosom Med | pmid:15673630 |
| Fernandes EO et al. | Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens. | 2005 | Pacing Clin Electrophysiol | pmid:15683490 |
| pmid:15686141 | ||||
| Weingertner AS et al. | [Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties]. | 2004 | J Gynecol Obstet Biol Reprod (Paris) | pmid:15687940 |
| Lammert M et al. | Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NF1 patients. | 2005 | BMC Cancer | pmid:15703081 |
| Burton JL and Saihan E | Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy [pproceedings]. | 1979 | Br. J. Dermatol. | pmid:157155 |
| Beksinska ME et al. | Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. | 2005 | Contraception | pmid:15722065 |
| Anand V and Gorard DA | Norethisterone-induced cholestasis. | 2005 | QJM | pmid:15728406 |
| Bassol S et al. | The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women. | 2005 | Maturitas | pmid:15734600 |
| Oguz S et al. | The role of hormone replacement therapy in endometrial polyp formation. | 2005 | Maturitas | pmid:15734604 |
| pmid:15744514 | ||||
| Adler G et al. | A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms. | 2005 | Gynecol. Obstet. Invest. | pmid:15753617 |
| Haarbo J et al. | Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. | 1992 | Circ. Res. | pmid:1576740 |
| Oliveira RL et al. | Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. | 2005 | Int. J. Cardiol. | pmid:15771927 |
| Christodoulakos G et al. | Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. | 2005 | Maturitas | pmid:15780533 |
| Brynhildsen J and Hammar M | Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. | 2005 | Maturitas | pmid:15780536 |
| pmid:15781412 | ||||
| Ewertz M et al. | Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. | 2005 | Br. J. Cancer | pmid:15785751 |
| Rothermund CA et al. | Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model. | 2005 | BMC Urol | pmid:15790403 |
| Miller AC et al. | Step-response analysis of chemotaxis in Caenorhabditis elegans. | 2005 | J. Neurosci. | pmid:15800192 |
| Djerassi C | Carl Djerassi discusses pills, plays and prizes. Interviewed by Samantha Barton and Jayne Carey. | 2005 | Drug Discov. Today | pmid:15809189 |
| Yasuda S et al. | Oral contraceptives as substrates and inhibitors for human cytosolic SULTs. | 2005 | J. Biochem. | pmid:15809343 |
| Junaidi A et al. | Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis). | 2005 | Eur. J. Endocrinol. | pmid:15817923 |
| Griffith SG and Dai Y | Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. | 2004 | Clin Ther | pmid:15823769 |
| Hofling M et al. | Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density. | 2005 | Gynecol. Endocrinol. | pmid:15823831 |
| pmid:15840751 | ||||
| D'Anna R et al. | The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. | 2005 | Acta Obstet Gynecol Scand | pmid:15842212 |
| pmid:15842506 | ||||
| pmid:15846228 | ||||
| Shirk RA et al. | Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15857755 |
| Honjo H et al. | Progestins and estrogens and Alzheimer's disease. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15860274 |
| Catanzaro LM and Morse GD | Data from clinical trials. | 2005 | J. Acquir. Immune Defic. Syndr. | pmid:15867609 |
| Heard I | Data from the French cohort studies and framing the French contraceptive guidelines. | 2005 | J. Acquir. Immune Defic. Syndr. | pmid:15867610 |
| Menendez JA et al. | The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. | 2005 | Int. J. Oncol. | pmid:15870863 |
| Al-Azzawi F et al. | Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate. | 2005 May-Jun | Menopause | pmid:15879923 |
| Talwar PP et al. | Endometrial control: a comparative study of three oral contraceptives. | 1976 | Int J Gynaecol Obstet | pmid:15901 |
| Vardy MD et al. | The effects of hormone replacement on the biomechanical properties of the uterosacral and round ligaments in the monkey model. | 2005 | Am. J. Obstet. Gynecol. | pmid:15902188 |
| Edelman DA et al. | An assessment of the side effects of switching from one oral contraceptive to another. | 1976 | Int J Gynaecol Obstet | pmid:15904 |
| Gallmeier E et al. | Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX. | 2005 | Carcinogenesis | pmid:15905198 |
| Murphy PA et al. | Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. | 2005 | Contraception | pmid:15914127 |
| Kim-Björklund T et al. | Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central? | 1992 | Contraception | pmid:1591922 |
| Nahas-Neto J et al. | Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy. | 2006 | Maturitas | pmid:15941630 |
| pmid:15957930 | ||||
| Modena MG et al. | New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. | 2005 | Maturitas | pmid:15963666 |
| pmid:15964400 | ||||
| Taner MZ et al. | Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. | 2006 | Maturitas | pmid:15978753 |
| Suparto IH et al. | A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy. | 2005 | Coron. Artery Dis. | pmid:16000888 |
| Zhou D et al. | [Study of drug displacement interactions by capillary electrophoresis-frontal analysis]. | 2005 | Se Pu | pmid:16013566 |
| Pluchino N et al. | Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. | 2005 | Gynecol. Endocrinol. | pmid:16019353 |
| Heald A et al. | Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. | 2005 | Gynecol. Endocrinol. | pmid:16019358 |
| Franke HR et al. | Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy. | 2005 | Gynecol. Endocrinol. | pmid:16019373 |
| Ng LF et al. | Host heterogeneous ribonucleoprotein K (hnRNP K) as a potential target to suppress hepatitis B virus replication. | 2005 | PLoS Med. | pmid:16033304 |
| Gallo MF et al. | Combination injectable contraceptives for contraception. | 2005 | Cochrane Database Syst Rev | pmid:16034938 |
| Rolnick SJ et al. | Hormone use and patient concerns after the findings of the Women's Health Initiative. | 2005 Jul-Aug | Menopause | pmid:16037754 |
| Krämer EA et al. | The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. | 2005 Jul-Aug | Menopause | pmid:16037763 |
| Naftolin F and Harman SM | Progesterone abolishes estrogen and/or atorvastatin endothelial dependent vasodilatory effects. | 2005 | Atherosclerosis | pmid:16039298 |
| Lindenmaier H et al. | Interaction of progestins with the human multidrug resistance-associated protein 2 (MRP2). | 2005 | Drug Metab. Dispos. | pmid:16049127 |
| Utian WH | Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. | 2005 | Health Qual Life Outcomes | pmid:16083502 |
| OsmanaÄŸaoÄŸlu MA et al. | Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women. | 2005 | Fertil. Steril. | pmid:16084879 |
| Mirkin S et al. | Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells. | 2005 | Fertil. Steril. | pmid:16084894 |
| Berger GS et al. | The probability of side effects with ovral, norinyl 1/50 and norlestrin. | 1979 | Contraception | pmid:160860 |
| Buhariwalla HK et al. | Development of ESTs from chickpea roots and their use in diversity analysis of the Cicer genus. | 2005 | BMC Plant Biol. | pmid:16107212 |
| Moss SF et al. | Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. | 1992 | Gut | pmid:1612493 |
| Koubovec D et al. | Synthetic progestins used in HRT have different glucocorticoid agonist properties. | 2005 | Mol. Cell. Endocrinol. | pmid:16125839 |
| Seeger H et al. | Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. | 2005 | Horm. Metab. Res. | pmid:16138258 |
| Kwok S et al. | Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. | 2006 | Maturitas | pmid:16139447 |
| Vitale C et al. | Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. | 2005 Sep-Oct | Menopause | pmid:16145309 |
| Rinaldi M et al. | Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis. | 2005 Sep-Oct | Menopause | pmid:16145317 |
| Bray JD et al. | Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:16157482 |
| Héctor FH et al. | Inhibition of the acrosome reaction (AR) and fertilization capacity of mouse spermatozoa by norethisterone A-ring reduced metabolite (5alpha-NET). | 2005 | Andrologia | pmid:16164431 |
| Brown CM et al. | Contraception in teens with medical problems. | 2005 | J Pediatr Adolesc Gynecol | pmid:16171736 |